A
Arijita Basu
Researcher at University of Calcutta
Publications - 12
Citations - 171
Arijita Basu is an academic researcher from University of Calcutta. The author has contributed to research in topics: Cell migration & PTEN. The author has an hindex of 6, co-authored 12 publications receiving 90 citations.
Papers
More filters
Journal ArticleDOI
Tailoring the Efficacy of Multifunctional Biopolymeric Graphene Oxide Quantum Dot-Based Nanomaterial as Nanocargo in Cancer Therapeutic Application
Sriparna De,Kartick Patra,D. Ghosh,Koushik Dutta,Aditi Dey,Gunjan Sarkar,Jyotirmay Maiti,Arijita Basu,Dipak Rana,Dipankar Chattopadhyay +9 more
TL;DR: Cellular uptake studies manifested that FA-CH-GOQD could specifically transport DOX within a cancerous cell and anticancer efficacy of this nanomaterial was corroborated in a breast cancer cell line and demonstrated through 4',6-diamidino-2-phenylindole dihydrochloride staining micrographs.
Journal ArticleDOI
Controlled delivery of tetracycline hydrochloride intercalated into smectite clay using polyurethane nanofibrous membrane for wound healing application
Kasturi Saha,Koushik Dutta,Arijita Basu,Arpita Adhikari,Dipankar Chattopadhyay,Priyabrata Sarkar +5 more
TL;DR: In this article, the effects of electrospinning for controlled drug delivery by using polyurethane monolithic nanofibrous web was explored, and the results showed that the nanoclay performed as a better way in the form of sustained drug release carrier.
Journal ArticleDOI
Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer.
Mousumi Bhattacharjee,Priyanka Upadhyay,Sushmita Sarker,Arijita Basu,Shaswati Das,Avijit Ghosh,Swatilekha Ghosh,Arghya Adhikary +7 more
TL;DR: TQ/Emo inhibited breast cancer proliferation synergistically while enhancing cytotoxicity, inducing apoptosis on MCF-7 cells while curbing migration & stemness, utilizing the synergism of the combinable therapy.
Journal ArticleDOI
Exploration of the potential efficacy of natural resource-derived blue-emitting graphene quantum dots in cancer therapeutic applications
Soumitra Ghorai,Indranil Roy,Sriparna De,Pratik Swarup Dash,Arijita Basu,Dipankar Chattopadhyay +5 more
TL;DR: The robust functionality, luminescence stability, nanosecond lifetime, biocompatibility, and low toxicity of the developed GQDs suggest they could be promising probes for cancer therapeutic applications.
Journal ArticleDOI
Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer
Arijita Basu,Priyanka Upadhyay,Avijit Ghosh,Aparajita Bose,Payal Gupta,Sreya Chattopadhyay,Dipankar Chattopadhyay,Arghya Adhikary +7 more
TL;DR: In this paper, Hylaluronic acid engrafted metformin loaded graphene oxide (HA-GO-Met) nanoparticles exhibited an anti-cancer efficacy at a much lower dosage as compared to METIN alone.